Company Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Biotechnology & Medical Research

Market Closed - Canadian Securities Exchange 14:30:00 05/07/2024 BST 5-day change 1st Jan Change
0.075 CAD -51.61% Intraday chart for Entheon Biomedical Corp. -51.61% -25.00%

Business Summary

Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is focused on treating addiction and substance-use disorders.

Number of employees: 1

Managers

Managers TitleAgeSince
Chief Executive Officer 39 30/06/19
Director of Finance/CFO - 06/01/23
Director/Board Member 46 31/12/19
Investor Relations Contact 41 30/04/19
Corporate Secretary 42 -
Corporate Officer/Principal - 03/02/21

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 39 30/06/19
Director/Board Member 46 31/12/19
Director/Board Member 53 04/11/20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 8,858,926 8,668,934 ( 97.86 %) 0 97.86 %

Shareholders

NameEquities%Valuation
Timothy Ko
23.69 %
1,400,001 23.69 % 217 000 $
Canal Front Investments, Inc.
15.40 %
910,000 15.40 % 141 050 $
50,000 0.8462 % 7 750 $
10,000 0.1692 % 1 550 $

Company contact information

Entheon Biomedical Corp.

999 West Broadway Suite 720

V5Z 1K5, Vancouver

+

http://www.entheonbiomedical.com
address Entheon Biomedical Corp.(ENBI)
  1. Stock Market
  2. Equities
  3. ENBI Stock
  4. Company Entheon Biomedical Corp.